Reading time:3 minutes, 9 seconds
The intrathecal pumps market report defines the intrathecal pumps market operating in clinical settings, which is expected to grow at a CAGR of 12% through 2022. The market includes manufacturers such as CR Bard, Smith & Nephew, Boston Scientific and Baxter Healthcare. Find out what industry experts are saying about the intrathecal pyramids market trends… Here is a comprehensive report on the intrathecal pumps market, presenting key market insights, growth analysis and forecasts to 2026.
What is the Intrathecal Pumps Market?
An intrathecal pump is a device that has been used for years to deliver intermittent positive pressure to an area of the brain or organ that requires a continuous flow of pituitary hormones. Intrathecal pumps are used to deliver substances into the central canal of the spinal cord instead of through the bloodstream. These pumps can be classified as emergency devices that stop any respiratory bleeding and provide life-saving therapy without requiring SCIOR placement or damaging neurons.
Click on the tab below to avail the sample copy of the report [email protected]
IV Pump Use Cases
Intrathecal pumps are used to treat a range of conditions in which IV fluids are needed. Hypotension or low blood pressure is the most common condition that patients need IV fluids for. Intrathecal pumps are generally used as an adjunct to the treatment of this condition and cannot be used as an alternative due to inadequate fluid delivery. The intrathecal pump market is expected to grow at a CAGR of 12.3% during the forecast period 2016-2020. Currently, North America holds more than 50% of the global intrathecal pump market. Asia-Pacific and Europe are expected to save 19% and 17% share by 2020. Intrathecal pump includes intermittent bolus intravenous therapy and continuous overnight therapy. The juvenile type is the leading segment, followed by the adult segment, while the pediatric part is late in demand.
Market size and growth forecast
The intrathecal pumps market is expected to grow from USD 3.2 billion in 2010 to USD 4.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2022. The global intrathecal pump market has been primarily driven by the prevalence of acute intrathecal therapies such as neurosurgery, spinal cord surgery, and organ transplantation, primarily due to technological advancements.
Key players in the Intrathecal Pumps market
Key players in the intrathecal pump market are Medtronic, Abbott Laboratories, Boston Scientific Corporation, and US WorldMeds. These companies offer a variety of products, including pumps for intrathecal chemotherapy and catheters for rheumatic disorders. Every day, many people around the world benefit from devices used to inject drugs directly into the spinal cord. Unfortunately, companies find it difficult to develop these products because they can only be used on patients who have undergone surgery in the central part of the spine, which makes them very expensive. However, there is a slight difference that patients experience when receiving medication through an intrathecal pump.
Click on the tab below for the instant purchase of the report with a flat rate discount of $500
Instant Buy Request
The overall market size was estimated at USD 33.71 million in 2018 and is projected to reach USD 36.14 million by the end of 2023, growing at a CAGR of 2.4% from 2019 to 2023. After analyzing The current performance of the market, it is clear that the global intrathecal pumps market will continue to grow healthily shortly. However, population-based studies reveal that the intrathecal pump loses its edge over all IV pumps and other methods of anesthesia due to the following factors. Ant aking airway: Intrathecal pump could damage the ET tube, causing asphyxiation, while intubation with an endotracheal line may cause greater harmful effects than mechanical ventilation.